Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine (Q66395913)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine |
clinical trial |
Statements
ACHIEVE II (English)
0 references
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Single Attack Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine (English)
0 references
26 August 2016
0 references
25 January 2018
0 references
1,686
0 references
18 year
0 references
75 year
0 references